Kevin Kalinsky, MD, MS, FASCO

Looking forward to this meeting!

.@eaonc is hosting a webinar on EA1241, a companion study for pts previously enrolled in TAILORx or RxPONDER. Investigators & #ClinicalResearch professionals are invited to register below. 📅Feb 4 | 4 PM ET 🎙 @jsparano, @KalinskyKevin, @RimapatelMD 🔗bit.ly/EA1241webinar

Join me at the 43rd Annual Miami Breast Cancer Conference! I'll be sharing insights alongside top experts to advance breast cancer care. Use my last name discount code for FREE registration. Register today: gotoper.com/mbccfof #MBCC25 #BreastCancerCare #BCSM

#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD

#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD

From #ASH —> #SABCS25! Look forward to seeing how this is going to change/inform our practice in breast cancer!! In Person: Dec 10, 2025 ⏰ Time: 7-9PM ✅ Register here: bit.ly/aiosabcs25 #OncTwitter #MedTwitter #bcsm #AdvInOnc25 @OncUpdates @OncoAlert

Trial Activation: EA1241, led by @jsparano of @MountSinaiNYC, is a companion study for patients who previously took part in either the TAILORx or RxPONDER #BreastCancer trials. For more information: bit.ly/EA1241 cc: @KalinskyKevin, @RimapatelMD

@jhaveri_komal Totally agree! And back at you @jhaveri_komal

Great faculty, fantastic discussions, looking forward to the next one already! Couldn’t do it without my partner in crime @KalinskyKevin

Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi When considering de-escalation in HER2+ early breast cancer, which factor most influences your decision?

Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi Are TIL levels currently influencing your treatment decisions in #TNBC in clinical practice? #breastcancer

In this episode of 5-Minute Journal Club, Dr Neil Love is joined by Dr Kevin Kalinsky to define the future role of TROP2-directed antibody-drug conjugates in breast cancer. Watch or listen here: ow.ly/5R5W50X4iy9

We kick-off the inaugural Atlanta Breast Cancer Conference with @KalinskyKevin welcoming attendees to discuss the care of multiple breast cancer subtypes. #AtlBreast25

Still time to register! Join our esteemmed faculty ⁦@EmoryUniversity ⁦@WinshipAtEmory⁩ Updates in #HNCA acrobat.adobe.com/id/urn:aaid:sc… on September 6th; ⁦@StokedStokes⁩ ⁦@NikkiSchmittMD⁩ ⁦@ConorSteuerMD⁩

Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at @WinshipAtEmory

The Glenn Family Breast Cancer Center invites you to the Inaugural Atlanta Breast Cancer Conference on Saturday, September 27, 2025. Learn more and register at bioascend.com/atlanta-breast/ #ATLBreast25

@Dr_RShatsky @UCSDHealthSci @UCSDCancer Congrats!!!

Happy to share that I was promoted to full Professor of Clinical Medicine this week at @UCSDHealthSci @UCSDCancer These don’t mean much for most of the population but for us #academic s it’s something we work pretty hard to achieve. ☺️

@Neil_Iyengar @WinshipAtEmory We are so excited!!!

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

📅 Join us tomorrow for our, Expert Analysis of the Top Abstracts From the 2025 Oncology Meeting. We’re bringing timely, expert-led insights straight to your practice. ✅ Practical strategies for patient care ✅ Designed for oncologists and cancer care teams ✅ CME-accredited Don’t miss it—register now and be part of the conversation with, @FordePatrick, @KalinskyKevin, @stolaney1 Register: bit.ly/45H9vwt

@YAbdouMD @paolazagam @ConquerCancerFd Back to you both! ❤️

@paolazagam @KalinskyKevin @ConquerCancerFd 💯 @KalinskyKevin is the best 🤩

It was a great honor to meet @KalinskyKevin,amazing oncologist and beautiful person! Thanks a lot for your and dr Keir support, endorsing my ASCO conquer cancer merit awar🏅. Great and interesting presentation of NATALEE trial by age and menopausal! @ConquerCancerFd #ASCO25

@paolazagam @ConquerCancerFd Honor was all ours! You did a fantastic job! Huge congrats!!!